248 related articles for article (PubMed ID: 25378241)
21. Insights into oxidative stress: the isoprostanes.
Montuschi P; Barnes P; Roberts LJ
Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157
[TBL] [Abstract][Full Text] [Related]
22. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans.
Galano JM; Mas E; Barden A; Mori TA; Signorini C; De Felice C; Barrett A; Opere C; Pinot E; Schwedhelm E; Benndorf R; Roy J; Le Guennec JY; Oger C; Durand T
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():95-102. PubMed ID: 23644158
[TBL] [Abstract][Full Text] [Related]
23. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
Piłacik B; Nofer TW; Wasowicz W
Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
[TBL] [Abstract][Full Text] [Related]
24. Formation of trans-epoxy fatty acids correlates with formation of isoprostanes and could serve as biomarker of oxidative stress.
Rund KM; Heylmann D; Seiwert N; Wecklein S; Oger C; Galano JM; Durand T; Chen R; Gueler F; Fahrer J; Bornhorst J; Schebb NH
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106334. PubMed ID: 31009766
[TBL] [Abstract][Full Text] [Related]
25. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
Mas E; Michel F; Guy A; Bultel V; Falquet Y; Chardon P; Rossi JC; Cristol JP; Durand T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):133-40. PubMed ID: 18706873
[TBL] [Abstract][Full Text] [Related]
26. New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo.
Yin H
Biofactors; 2008; 34(2):109-24. PubMed ID: 19706977
[TBL] [Abstract][Full Text] [Related]
27. Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay.
Musiek ES; Cha JK; Yin H; Zackert WE; Terry ES; Porter NA; Montine TJ; Morrow JD
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(1):95-102. PubMed ID: 14659440
[TBL] [Abstract][Full Text] [Related]
28. Dihomo-isoprostanes-nonenzymatic metabolites of AdA-are higher in epileptic patients compared to healthy individuals by a new ultrahigh pressure liquid chromatography-triple quadrupole-tandem mass spectrometry method.
Medina S; Miguel-Elízaga ID; Oger C; Galano JM; Durand T; Martínez-Villanueva M; Castillo ML; Villegas-Martínez I; Ferreres F; Martínez-Hernández P; Gil-Izquierdo Á
Free Radic Biol Med; 2015 Feb; 79():154-63. PubMed ID: 25464272
[TBL] [Abstract][Full Text] [Related]
29. Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.
Song WL; Paschos G; Fries S; Reilly MP; Yu Y; Rokach J; Chang CT; Patel P; Lawson JA; Fitzgerald GA
J Biol Chem; 2009 Aug; 284(35):23636-43. PubMed ID: 19520854
[TBL] [Abstract][Full Text] [Related]
30. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
Roberts LJ; Morrow JD
Free Radic Biol Med; 2000 Feb; 28(4):505-13. PubMed ID: 10719231
[TBL] [Abstract][Full Text] [Related]
31. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
Morrow JD
Curr Pharm Des; 2006; 12(8):895-902. PubMed ID: 16533158
[TBL] [Abstract][Full Text] [Related]
32. Electrophilic cyclopentenone isoprostanes in neurodegeneration.
Musiek ES; McLaughlin B; Morrow JD
J Mol Neurosci; 2007 Sep; 33(1):80-6. PubMed ID: 17901550
[TBL] [Abstract][Full Text] [Related]
33. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid.
Nourooz-Zadeh J; Halliwell B; Anggård EE
Biochem Biophys Res Commun; 1997 Jul; 236(2):467-72. PubMed ID: 9240462
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
Musiek ES; Yin H; Milne GL; Morrow JD
Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
[TBL] [Abstract][Full Text] [Related]
36. Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo.
Hardy KD; Cox BE; Milne GL; Yin H; Roberts LJ
J Lipid Res; 2011 Jan; 52(1):113-24. PubMed ID: 20944061
[TBL] [Abstract][Full Text] [Related]
37. The isoprostanes: unique bioactive products of lipid peroxidation.
Morrow JD; Roberts LJ
Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
[TBL] [Abstract][Full Text] [Related]
38. Development of an LC-ESI(-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs.
Rund KM; Ostermann AI; Kutzner L; Galano JM; Oger C; Vigor C; Wecklein S; Seiwert N; Durand T; Schebb NH
Anal Chim Acta; 2018 Dec; 1037():63-74. PubMed ID: 30292316
[TBL] [Abstract][Full Text] [Related]
39. F2-isoprostanes are not just markers of oxidative stress.
Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
[TBL] [Abstract][Full Text] [Related]
40. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
Morrow JD
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):279-86. PubMed ID: 15591226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
